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ABSTRACT  
Cationic polymers have recently attracted attention due to their proven potential for nonviral gene 
delivery. In this study, we report novel biocompatible nanocomplexes produced using chemically 
functionalized N,N,N-trimethyl chitosan (TMC) with different N-acyl chain lengths (C5–C18) 
associated with single-stranded oligonucleotides. The TMC derivatives were synthesized by covalent 
coupling reactions of quaternized chitosan with n-pentanoic (C5), n-decanoic (C10), and n-
octadecanoic (C18) fatty acids, which were extensively characterized by Fourier transform-infrared 
spectroscopy (FT-IR) and proton nuclear magnetic resonance (1H NMR). These N-acylated TMC 
derivatives (TMCn) were used as cationic polymeric matrices for encapsulating anionic 18-base single-
stranded thiophosphorylated oligonucleotides (ssONs), leading to the formation of polyplexes 
further characterized by zeta potential (ZP), dynamic light scattering (DLS), binding affinity, 
transfection efficiency and in vitro cytotoxicity assays. The results demonstrated that the length of 
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the grafted hydrophobic N-acyl chain and the relative amino:phosphate groups ratio (N/P ratio) 
between the TMC derivatives and ssON played crucial roles in determining the physicochemical 
properties of the obtained nanocomplexes. While none of the tested derivatives showed appreciable 
cytotoxicity, the type of acyl chain had a remarkable influence on the cell transfection capacity of 
TMC–ssON nanocomplexes with the derivatives based on stearic acid showing the best performance 
based on the results of in vitro assays using a model cell line expressing luciferase (HeLa/Luc705). 
 INTRODUCTION  
Since publication of the original report by Zamecnik and Stephenson1 demonstrating that DNA 
oligonucleotides could inhibit Rous sarcoma virus replication in cell culture, synthetic 
oligonucleotides (ONs) have been used as vectors for antisense gene therapy when coupled with 
different nonviral vectors.2–4 Antisense oligonucleotides (AONs) are synthetic, short, single-stranded 
RNA or DNA molecules that have complementary sequences to targeted mRNA or precursor (pre)-
mRNA; selective hybridization between the AONs and the target sequence inhibits gene 
expression.4,5 Because of the sequence-specific nature of the double helix, oligonucleotide-based 
systems offer the possibility of targeting the desired genes without affecting other genes, making 
such systems valuable tools to elucidate the biological roles of specific proteins and for use in various 
genetic-driven therapies for the treatment of human diseases.6–8 However, the therapeutic 
applications of oligonucleotide-based systems are restricted by the relatively low stability of these 
molecules in the presence of intra- and extracellular nucleases in biological fluids, their short half-life 
in vivo, and their poor intracellular penetration due to the negative charge of the single-stranded ON 
(ssON, having a phosphate backbone).3  
In order to increase their stability and ability to penetrate the plasma membrane, chemical 
modifications have been introduced;9 however, such modified ssONs require high concentrations to 
achieve a good response and this with the lack of specific cell-targeting ability raises concerns with 
potential cytotoxicity. For this reason, novel strategies for the development of effective, accurate, 
specific, and nontoxic carrier vectors for ssON delivery are needed.3,6–8,10 Nucleic acid delivery vectors 
are generally classified as either viral or non-viral vectors. For safety and financial reasons, non-viral 
vectors (i.e., synthetic delivery systems) are the preferred method for gene delivery.2,11,12 However, 
synthetic delivery systems also present some challenges, such as low gene transfer efficiency, 
cytotoxicity, and lack of cell-targeting capacity.11  
Cationic lipid- and cationic polymer-based systems are the major types of non-viral carriers used for 
biomedical applications. Cationic polymers mediate transfection via the condensation and 
encapsulation of negatively charged nucleic acids into particles of virus-like dimensions, providing 
protection from enzymatic degradation and facilitating cellular uptake and endolysosomal escape, 
thus representing excellent candidates for gene delivery.13–22 Among the potential cationic polymers, 
chitosan and its derivatives are attractive potential nucleic acid vectors. Chitosan is a natural linear 
copolymer composed of randomly distributed N-acetyl glucosamine and d-glucosamine, varying in 
composition, sequence, and molecular chain length. Because of its amine moieties, which can be 
protonated to impart pH-responsiveness to the chitosan-based drug carrier systems, chitosan 
possesses beneficial physicochemical properties with versatility for countless therapeutic 
applications. Furthermore, chitosan exhibits biodegradability, a good safety profile, 
biocompatibility, and muco-adhesive and permeability-enhancing properties.22 However, the 
transfection efficiency of chitosan is low under physiological conditions because of its poor water 
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solubility, aggregation, and flocculation at physiological pH (pKa ∼ 6.5) and the inability to release 
the nucleic acid after endosomal escape.22–24 Consequently, in order to overcome these 
disadvantages, several chemical modifications of chitosan using hydrophilic and hydrophobic 
moieties have been reported.24–27 However, modifications do not generally change the fundamental 
properties of chitosan, but instead introduce new properties. For example, a cationic chitosan 
derivative, N,N,N-trimethyl chitosan (TMC), which exhibits higher solubility in water over a broad 
range of pH values, including at physiological pH, has been synthesized to have the potential for 
biomedical applications, such as gene delivery vectors.12,22,24 The degree of quaternization of 
chitosan, which is desirable to improve the stability of ionic complexes with nucleic acids, plays an 
important role in its gene transfection efficiency and cytotoxicity. Nonetheless, the strong 
electrostatic interaction between TMC and nucleic acids may also restrict gene delivery inside the 
cells, thus leading to low transfection rates. Therefore, further improvement of the gene delivery 
efficiency and biocompatibility of cationic chitosan derivatives is still required.5,12,22  
In the last decade, much progress has been made by grafting hydrophilic or hydrophobic chains to 
the backbone of chitosan and quaternized-chitosan derivatives.24,28,29 Among these novel 
compounds, hydrophobic group-modified chitosan has been investigated for increasing gene 
transfection efficiency. In a variety of settings, hydrophobic chains have been shown to alter the 
interaction between polyplexes (i.e., complexes formed between a polymeric vector and nucleic acid) 
and the cell membrane, facilitating intracellular DNA dissociation, promoting cell uptake, and 
enhancing the unpacking of genes from the vectors.28,30,31 Surprisingly, considering the enormous 
potential of using ssON-based systems in gene therapy,3,6,8,31,32 few reports have described the use 
of chitosan-based vectors as ssON delivery platforms.6,7,31 Here, we endeavor to demonstrate the 
influence of different N-acyl chain lengths focusing on the physicochemical aspects of TMC/ssON 
polyplexes in terms of their chemical and biochemical stability, charge balance, and dimension, while 
reporting on their preliminary transfection efficiencies in an in vitro splice correction system.  
2. Experimental  
2.1. Materials  
TMC from a fungal source (89% deacetylated and 30% quaternization) was supplied by Kitozyme 
(Belgium). Decanoyl chloride [CH3(CH2)8COCl], valeroyl chloride [CH3(CH2)3COCl], pyrene, acetic 
acid, sodium hydroxide, ethanol, methanol, and diethyl ether of analytical grade were purchased 
from Sigma-Aldrich (St. Louis, MO, USA). Stearic acid N-hydroxysuccinimide ester 
[CH3(CH2)15CH2CO–NHS] was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 2-(N-
Morpholino)ethanesulfonic acid (MES) and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) were purchased from Sigma-Aldrich. The 18-base ssON 2′O-methyl-RNA (SCO705: 
CCUCUUACCUCAGUUACA) was purchased from Integrated DNA Technologies (IDT, USA). 
Lipofectamine® 2000 Transfection Reagent and Dulbecco's modified Eagle's medium (DMEM) were 
supplied by Life Technologies, Inc. (USA). Unless indicated otherwise, deionized (DI) water (Millipore 
Simplicity) with a resistivity of 18 MΩ cm was used to prepare the solutions, and the procedures were 
conducted at room temperature (20 ± 3 °C).  
2.2. Functionalization of N,N,N-trimethyl chitosan with fatty acids  
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Before further chemical modification, TMC was purified. One gram of TMC was dissolved in 200 mL 
of DI water, and magnetically stirred for 2 h. Glacial acetic acid was then added dropwise until pH 5 
was reached. The solution was diluted to 300 mL with DI water, and was magnetically stirred at room 
temperature (rt) for 2 h. The resulting suspension was filtered through a sintered glass filter (pore size 
100–160 μm, Duncan) and TMC was precipitated using an ethanol : diethyl ether (1 : 1) mixture and 
10 M NaOH solution (dropwise) until pH 9 was reached. The precipitated TMC was centrifuged for 5 
min at 5000 rpm. The supernatant was then decanted, and the TMC in the bottom of the FalconBD 
tube was washed with ethanol. The purified TMC was dissolved in DI water and lyophilized (−80 °C/72 
h, Labconco). The purified polymer was characterized by gel permeation chromatography (GPC). The 
weight average molecular weight of the purified TMC was found to be 43.3 ± 5 kDa (GPC in 0.33 M 
NaCH3COOH/0.28 M CH3COOH, pH 4, 25 °C).  
Next, TMC was acylated by reaction between its amine groups and the acyl chloride or N-
hydroxysuccinimide (NHS) derivatives of the corresponding fatty acids.  
2.2.1. Pentanoyl (or valeroyl, TMC-C5) and decanoyl modifications 
(TMC-C10)  
Dried (60 °C, 24 h in a vacuum oven) purified TMC (50 mg) was added to a 0.5 M phosphate buffer pH 
7.4 solution (6.2 mL). After 12 h of stirring, in order to ensure total solubility, the solution was 
transferred to a round-bottom flask, and 9.4 mL of methanol was added. The mixture was 
magnetically stirred under reflux (50 °C) for 1 h, and then, 9.4 mL of acyl chloride (valeroyl or 
decanoyl, 0.85 w/v%) solution in methanol was added dropwise. The reaction mixture was 
moderately stirred under reflux (50 °C) for 8 h. The resulting mixture was dialyzed (Spectra/Por 3 
Dialysis Membrane, MWCO 3.5 kDa) against distilled water for 72 h. The dialyzed product was 
lyophilized and subsequently washed with ethanol. Finally, the modified TMC-C5 and TMC-C10 were 
dispersed in DI water and lyophilized for 72 h.  
2.2.2. Octadecanoyl (or stearyl, TMC-C18) modification  
This modification was performed as previously described.31 Briefly, dried (60 °C, overnight, in a 
vacuum oven) TMC (50 mg) was added to a 0.1 M MES buffer pH 6.5 solution (6.2 mL) and stirred for 
12 h at 37 °C to ensure complete solubilization. The solution was transferred to a round-bottom flask, 
and methanol (9.4 mL) was added. The reaction mixture was magnetically stirred under reflux (50 °C) 
for 1 h. Then, 9.4 mL of a solution of stearic acid N-hydroxysuccinimide ester (0.26 w/v%) in methanol 
was added dropwise. The resulting mixture was stirred for 24 h, and then dialyzed using the 
abovementioned procedure described for TMC-C5 and TMC-C10. Finally, the modified TMC-C18 was 
dispersed in DI water and lyophilized for 72 h.  
2.2.3. Characterization  
The coupling of fatty acids on the TMC backbone was confirmed by proton nuclear magnetic 
resonance (1H NMR) and Fourier transform-infrared spectroscopy (FT-IR). NMR spectra were 
recorded on a Bruker Avance III 400 MHz spectrometer in 2.7% DCl in D2O : CD3OD (1 : 1) at 323 K. 
Chemical shifts are reported in ppm (δ units) downfield from internal tetramethylsilane.  
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The degree of substitution (DS) with fatty acids was determined by integration of the appropriate 
signals (fatty acid methyl group and TMC acetyl groups) in the 1H NMR spectrum, and calculated 
using eqn (1):31 
 
FT-IR was used to determine the presence of specific chemical groups in TMC and N-acyl TMC 
derivatives. FT-IR was performed over the range from 650 to 4000 cm−1 (Thermo Fischer, Nicolet 
6700) using the attenuated total reflectance spectroscopy method (ATR). TMC and functionalized 
TMC flakes were placed on the ATR crystal prism (ZnSe), and 64 scans were acquired at 2 cm−1 
resolution with background subtraction.  
2.3. Polyplex formation and characterization  
TMC and TMC-modified polymers were dissolved in 5 mM HCl and 20 mM HEPES containing 5 w/v% 
glucose (pH 7.4) at a concentration of 3.0 mg mL−1. Polymer/ssON polyplexes with various N/P ratios 
(the N/P ratio was calculated from the quaternary amino groups of the polymer and the number of 
phosphate groups of the ssON) were prepared by heating the polymer and ssON solutions separately 
at 60 °C for 5 min, followed by addition of the appropriate volume of ssON solution into the polymeric 
solution under vortexing. The mixture was then further incubated for 10 min at 60 °C under agitation 
(800 rpm). The mixture was finally left to cool down and stabilize at room temperature for 30 min.  
The mean hydrodynamic diameter (HD) and zeta potential (ZP) of the polyplexes were determined 
using a Zetasizer Nano ZS (Malvern, UK) by photon correlation spectroscopy and electrophoretic 
mobility, respectively. All measurements were performed in triplicate at 25 ± 2 °C.  
2.4. Interaction strength  
The strength of interaction between TMC and ON-modified TMCs was determined by gel retardation 
assays using polyacrylamide gels (10–20%) in Tris/borate/sodium ethylenediaminetetraacetic acid 
(EDTA) buffer (TBE buffer, containing 0.089 M Tris base, 0.089 M boric acid, and 2 mM EDTA, pH 
8.3). TMC/ON particles with different N/P ratios were directly loaded into the gel. Electrophoresis was 
performed at a constant voltage of 110 ± 1 V for 45 min. The gels were stained with SYBR Gold nucleic 
acid stain and visualized using an imager (Gel Doc XR; Bio-Rad, Hercules, CA, USA).  
2.5. Nanoparticle stability in serum  
TMC/ON complexes were diluted in a 1 : 3 ratio with DMEM (containing 4500 mg L−1 glucose) and 
glutamax, supplemented with 10% fetal bovine serum (FBS, Gibco) and incubated at 37 °C for 1 h. 
The average HD of the polyplexes after incubation was determined by dynamic light scattering (DLS) 
using a Zetasizer Nano ZS (Malvern) at 25 ± 2 °C. EMSA analysis (as described above) was also 
employed after complexes were incubated in serum containing medium.  
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2.6. Critical aggregation concentration (CAC) of modified TMCs  
The CAC of fatty acid-modified TMCs was measured using pyrene (Synergy Mx, BioTek Instruments, 
USA), which acts as a hydrophobic probe in fluorescence spectroscopy.33–39 For CAC experiments, 
TMC derivative solutions were prepared in 20 mM HEPES buffer containing 5 w/v% glucose (pH 7.4). 
A specific volume of pyrene aqueous solution (the final concentration of pyrene was controlled at 60 
μM) was added under vortexing (3 s) and heated overnight to equilibrate the aggregates. The sample 
solutions containing pyrene (60 μM) were excited using high-energy xenon flash at constant intensity 
(Synergy Mx). The concentration of TMCs and fatty acid-modified TMCs in solution varied from 10.0 
to 2.0 mg mL−1. For measurement of the intensity ratio of the first (372 nm) and third (383 nm) highest 
energy bands (I1/I3) in the emission spectra of pyrene, the excitation wavelength was 317 nm with an 
integration time of 10 s nm−1.37  
2.7. In vitro transfection  
HeLa/Luc705 cells were cultured in DMEM with 10% FBS and 50 μg mL−1 gentamycin. HeLa cells were 
plated 24 h before transfection (6 × 104 cells per well) in 24-well plates. On the day of transfection, 
the medium was replaced with DMEM containing 10% FBS without antibiotics. TMC complexes were 
prepared as described above, and Lipofectamine® 2000 was used to prepare control complexes 
following the manufacturer's protocols. The TMC-derivative/ssON complexes were added dropwise 
to each well of the plate until the final volume of 300 μL was achieved, and incubation was performed 
for 48 h, during which one volume of fresh complete medium (with no antibiotics) was added to the 
wells after 24 h.  
Cells were harvested in Hank's Krebs Ringer (HKR) lysis buffer (130 mM NaCl, 5 mM KCl, 1.2 mM 
MgSO4, 1.2 mM CaCl2, 20 mM HEPES, 1.2 mM Na2SO4, 10 mM glucose, pH 7.3, with the addition of 
0.15 v/v% Triton X-100). The level of luciferase expression was analyzed based on a luciferase activity 
assay (Luciferase Assay System; Promega, Madison, WI, USA) and the total protein was measured 
using a BCA protein assay (BCA protein assay kit, Thermo Scientific-Pierce Protein Research 
Products, USA).  
2.8. Cellular interaction/uptake  
The cellular interaction of TMC/ssON nanocomplexes was analyzed by flow cytometry analysis. Cells 
were seeded (60 000 cells) 24 h prior to transfection in 24-well plates. They were incubated with 
nanocomplexes (as described previously) for 4 h. Chitosanase (Merk Millipore) (3 mU chitosanase per 
μg of TMC) in DMEM with pH adjusted to 6.5 was then added to the cells, by completely replacing 
the previous medium, and incubated for 1 h at 37 °C. Cells were then trypsinized, washed 2× with PBS 
and finally resuspended in PBS + 2% FBS. Cells were run on a FACSCalibur flow cytometer (BD 
Biosciences) and data were analyzed using FlowJo software (FlowJo, LLC).  
2.9. Cell toxicity (metabolic activity)  
HeLa/Luc705 cells were seeded in 24-well plates (4 × 104 cells) 24 h prior to transfection in order to 
have 50% confluency. Nanocomplexes prepared as described previously and L2k based complexes 
were incubated with cells for 24 h. The medium was then replaced with 300 μL of fresh complete 
medium containing 10 (v/v)% resazurin (from an initial stock of 0.1 mg mL−1 in PBS, Sigma) in PBS. 
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Cells were incubated for 1.5 h at 37 °C after which 200 μL of the medium was transferred to a black 
96-well plate (Brand Plates, Brand GMBH, Germany) and fluorescence (kexc = 530 nm, kem = 590 nm) 
was measured on a multi-mode microplate reader (SynergiMX, Biotech). Results were expressed as 
relative fluorescence units (RFU).  
3. Results and discussion  
3.1. Functionalization of N,N,N-trimethyl chitosan with fatty acids  
TMC was functionalized with different fatty acids: valeroyl (A), decanoyl (B) and stearyl (C) chains 
(Scheme 1). The grafting of fatty acids was confirmed by FT-IR and 1H-NMR.  
1H-NMR spectra (D2O : MeOD : DCl) of the original and N-acylated TMC polymers are shown in Fig. 1. 
As spectra were recorded in (D2O : MeOD : DCl), the MeOH-d4 quintuplet (3.25 ppm) overlaps the 
N(CH3)3 peak (3.24 ppm), and hence for clarification, the original TMC was also recorded in D2O and 
shown in Fig. S1 (ESI†). In the spectrum of the TMC sample prior to modification (Fig. 1A; see Fig. S1 
for TMC spectrum in D2O, ESI†), the peak at 2.0 ppm revealed the three N-acetyl protons of the N-
acetyl glucosamine residue. The saccharide ring protons of chitosan are thought to resonate at 
approximately 3.4–5.0 ppm.31,33,34 Consistent with this, TMC characteristic peaks at 3.2–3.3 and 2.0–
2.1 ppm, which are assigned to hydrogen protons of the trimethylated quaternary residue [–N(CH3)3] 
and acetylated residue (–NCOCH3), respectively, were present in all spectra (Fig. 1 and Fig. S1, ESI†), 
as expected.31,33,34–36 The incorporation of fatty acid residues was established because of the 
appearance of the signals corresponding to the acyl chain protons: new peaks ranging from 0.8 ppm 
(CH3−) to 2.28 ppm corresponding to the hydrocarbon backbone of the fatty acyl residues were 
observed in the spectra of TMC-modified samples (Fig. 1B–E). Furthermore, DS values were 
calculated based on eqn (1) using the 1H NMR analyses (acetamide peak as a reference) for all TMC-
modified polymers, as summarized in Table 1. For all samples, DS values ranged from 1.7% to 3.8%, 
except for the sample TMC-VA_9. The higher DS value (9.1%) obtained specifically for TMC-C5_9 
could be explained by the changes in the relative concentrations of reagents during synthesis in order 
to verify the capacity for improving the degree of fatty acid substitution. Notably, a DS value ranging 
from 1% to 10% was expected for the acylation of TMC based on the reaction conditions using 
buffered solutions at approximately neutral pH (pH 7.4, slightly above the pKa 6.5 of chitosan), as was 
used in our experiments, where N-acylation (primary amine groups) was preferred over O-acylation 
(C3 and C6 alcohol groups) of TMC.24,39 Moreover, taking into account the relatively high degree of 
quaternization of TMC (approximately 30%), calculated as previously described31 based on the 1H 
NMR spectrum of TMC (Fig. 1A and Fig. S1, ESI†), some restrictions on the N-acylation mechanism 
of TMC were expected. In particular, significant conformational and kinetic limitations were expected 
mostly due to the steric hindrance and balance of charges caused by the cationic trimethyl-
quaternized amine groups [–N(CH3)3, adjacent to the reacting sites of TMC (primary amines, –NH2)].36  
The FT-IR spectrum of pure TMC [Fig. 2A(a)] exhibited absorption peaks at 3400–3200 cm−1 (νOH 
overlapped with νNH, and hydrogen bonds), 3000–2800 cm−1 (νCH), 1650–1640 cm−1 (νC O amide I), 
1590–1570 cm−1 (δNH primary amine), 1560–1550 cm−1 (δNH amide II), and 1420–1380 cm−1 (δCH). 
Bands at 1321 cm−1, 1260 cm−1, and 1380 cm−1 were associated with the bending vibrations of primary, 
secondary, and tertiary amides (δC–N), respectively. In addition, the absorption peaks at 1020–1050 
cm−1 and 1070–1110 cm−1 indicated the C–O stretching vibrations in chitosan, which are related to the 
C6–OH primary alcohol and the C3–OH secondary alcohol, respectively. The bands at 1160 cm−1 and 
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996 cm−1 were assigned to the vibrations of the C–O–C saccharide bridge.25 A characteristic band of 
TMC was observed at approximately 1480 cm−1, which is attributed to the asymmetric angular 
deformation of the methyl groups of quaternized chitosan.27 
FT-IR spectroscopy was also performed for a more detailed investigation of the chemical reaction 
leading to the formation of the acyl TMC derivatives TMC-C5_3 [Fig. 2A(b)], TMC-C5_9 [Fig. 2A(c)], 
TMC-C10_2 [Fig. 2A(d)], and TMC-C18_2 [Fig. 2A(e)]. By comparing the FT-IR spectra of TMC [Fig. 
2A(a)] and TMC-modified polymers [Fig. 2A(b)–(e)], the vibrational band corresponding to the 
primary amine groups (1590–1570 cm−1) was reduced due to the reaction, while the absorption band 
at 1555 cm−1 (amide II), which was associated with the formation of new amide bonds due to the 
acylation reaction, was increased. The same trend was observed for the stretching C–H vibration 
band at 2920 cm−1, which was related to the CH2 groups, and its relative intensity was proportional 
to the acyl chain length and DS.25,27–29 In addition, we observed two new bands, 2960 cm−1 and 2848 
cm−1, which were characteristic of fatty acids, and the amide I band was split into two bands, i.e., 1655 
cm−1 and 1637 cm−1, indicating the presence of two types of amide groups (from N-acetyl-d-
glucosamine repeat units and acylation reaction) due to the different intra- and intermolecular chain 
interactions.27–29  
Because FT-IR may be used for performing semi-quantitative analysis using the ratio of absorbance 
intensities (height or peak areas), Fig. 2B shows the evolution of amide II (1555 cm−1) and νC–H (2918 
cm−1) bands, using the C–O stretching band at 1070 cm−1 as an internal reference band.24 The increase 
in these bands in the acyl TMC sample provided additional evidence of the formation of a covalent 
linkage between the fatty acids and the NH2 groups of the TMC chain.  
3.2. Characterization of N-acylated-TMC/ON polyplexes  
3.2.1. Characterization of polyplexes by DLS  
For biomedical and pharmaceutical applications, the particle size and surface charge of polyplexes 
are crucial factors that modulate cellular uptake of the polyplexes.3 The formation of nanoparticles is 
aimed at nucleic acid protection from endonuclease degradation and enhanced cellular uptake. 
Generally, nanoparticles are internalized into cells easier than microparticles.3 In particular, for 
nucleic acid delivery with cationic polymers, the size distribution of polyplexes will be significantly 
influenced by the overall balance of charges and chemical interactions between the positively 
charged polymer chains and the negatively charged nucleotide strands.3,8,14 For colloids and 
dispersions in aqueous media, particle size is most often assessed using DLS analysis by measuring 
the HD.  
Therefore, in this study, we investigated the physicochemical properties and stability of polyplexes 
formed by TMC-R/ssON (i.e., R = N-acyl chain length, C5, C10, C18; ssON = 18-base oligonucleotide) 
in terms of their particle size and ZP as a function of the N/P (polymer/ON) ratio. TMC-R/ssON 
polyplexes were prepared in 20 mM HEPES buffer at physiological pH (7.4) envisaging a potential in 
vivo application in the future. The average particle sizes of TMC-R/ssON polyplexes as a function of 
the N/P ratio are shown in Fig. 3. For all the materials, the size of the resulting nanopolyplexes showed 
similar trends as a function of the N/P ratio (Fig. 3A). In other words, for samples with N/P ratios of 
more than 10, the average polyplex size typically ranged from ∼90 to 300 nm with a polydispersity 
index of approximately 0.1–0.6 (Fig. 3B). Notably, at lower N/P ratios (N/P = 10), both TMC/ON and 
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TMC-R/ON systems formed relatively large particles compared to the corresponding samples at 
higher N/P ratios (∼20–160); this observation may be explained by potential aggregation of the 
particles. Additionally, when the N/P ratio was increased to 20, all systems showed a significant 
reduction in the size of the polyplex particles. Further augmentation of the N/P ratio above 40 did not 
result in detectable changes in particle size, with the exception of an occasional slight increase. This 
phenomenon may be attributed to the aggregation of polyplexes, which may occur in the presence 
of higher concentrations of TMC molecules, as verified by an increase in the polydispersity index (Fig. 
3B). This index involves several factors due to the complex balance of electrostatic forces between 
positively charged TMC derivatives (TMC-Rs) and negatively charged ONs, combined with 
hydrophilic and hydrophobic interactions. Additionally, some conformational restrictions of TMC-R 
chains are involved due to the steric hindrance of the trimethyl amine groups with grafted-acyl 
groups.12,38,40 Moreover, the enhanced charge repulsion of the cationized TMC at higher N/P ratios 
may also explain some of the minor increases in size. Nonetheless, the N-acyl length undeniably 
affected the average HD values of the polyplexes. As shown in Fig. 3A, at high N/P ratios, ranging from 
80 to 160, the average particle size decreased when the length of the acyl chain increased (TMC-R, R 
= C5, C10, or C18). In addition to the abovementioned interactions involved in the formation of 
polyplexes, this trend was interpreted as representing additional relevant thermodynamic 
contributions derived from (i) hydrophobic attractive forces between the acyl chains of TMC-Rs and 
the ssONs' nitrogenous bases (as these have slight apolar characteristics), leading to better 
condensation;3,15,34 (ii) intra- and inter-molecular interactions between the hydrophobically modified 
polymer chains, resulting in a tendency for self-assembly into aggregates on the nanometer scale in 
an aqueous environment. Indeed, hydrophobically modified chitosan has been shown to self-
aggregate with several hydrophobic domains.3,41–43 However, in the context of target application for 
nucleic acid delivery, it is important to highlight that the HD of most of these polyplexes, which were 
produced based on N-acylated TMC/ON within the range of 100–200 nm, are consistent with the 
dimensions of nonviral nanoparticles suitable for cellular endocytosis.2,3  
3.2.2. Characterization of polyplexes by measurement of the ZP  
The overall balance of electrostatic charges on the particle surface in aqueous colloidal systems is 
critical for determining the physicochemical stability of the particles; this can be accessed by 
measurement of the ZP.8 Thus, the ZPs of polymers and TMC-R/ON polyplexes at N/P = 80 are 
depicted in Fig. 4. In general, at physiological pH (i.e., pH 7.4), all of the systems presented a net 
positive charge, regardless of the presence or length of the N-acyl chain, which is attributed to the 
permanent cationic characteristics of the quaternized-chitosan (TMC) used for the preparation of 
TMC derivatives. The most important feature of this system was that the ZP values were decreased 
after the ssON was added to each TMC system, indicating that the negative ssON molecules 
interacted with the positive TMC-R polymer. These results of ZP values for the TMC/ON polyplexes 
are interesting considering their potential application as a non-viral gene delivery platform, based on 
the observation that negatively charged cellular membranes tend to interact with positive ions, 
molecules, and particles. Thus, the complexes formed between the TMC derivatives developed in this 
study and ssONs possess a surface charge that is compatible with membrane interactions leading to 
cell uptake. According to the literature, the ideal ZP is slightly above or close to 0 mV, because the 
purpose of such modifications is to enhance binding to cell membranes, while excessive positive 
charge can raise cell toxicity issues.3,22,44,45  
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3.3. Stability of nanoparticles: in vitro binding affinity assay at 
physiological pH  
The relative in vitro binding affinity of the TMC derivatives towards ONs during the formation of 
polyplexes at different N/P ratios was evaluated under physiological pH conditions (20 mM HEPES 
buffer plus 5 m/v% glucose, pH = 7.4) using a gel retardation assay, as presented in Fig. S2, ESI†. This 
assay allows an evaluation of how strong is the interaction between the polymer and the ONs as 
unbound or weakly bound ONs will migrate through the gel when subjected to electrophoresis, 
whereas strongly bound ONs will remain in the wells together with the polymer (as the size of the 
complexes does not allow gel migration). As a general trend, at very low N/P ratios (e.g., 0.5 and 1.0), 
practically all samples showed low binding affinity, apparently caused by the relatively low polymer 
content, preventing condensation of the polyplexes. On the other hand, at high N/P ratios (typically 
above 6), all samples showed high binding affinity, likely as a result of the stabilization of the system 
due to the increase in the relative cationic strength at higher polymer concentrations, balancing the 
negative charge of the ONs. The complexes formulated with TMC-C18_2/ON show the highest 
retardation of ON mobility, suggesting the strongest binding between the polymer and the ON in 
comparison to unmodified, confirming previous observations31 and the shorter chain acyl-modified 
polymers. In contrast, the complexes formulated with TMC-C10_2 showed the weakest gel 
retardation effect of all systems, even compared with the unmodified TMC polymer, indicating that 
the overall balance of forces involved in the complexation had deteriorated the binding affinity 
between the TMC-C10_2 and ON. Quantitative analysis of unbound ON was also performed on the 
TMC/ON polyplex samples submitted to the gel electrophoresis retardation assay (Bio-Rad imaging 
software, ChemiDoc™ System, USA) and the results are presented in Fig. 5.  
3.4. Stability of nanoparticles: in vitro binding affinity assay in the 
presence of serum  
The suspension of the polymeric nanoparticles in a cell culture medium containing serum can 
represent a strong stressor for complexes because serum proteins can adsorb onto the surfaces of 
the nanoparticles by electrostatic interactions and promote destabilization. Hence, preventing the 
possible premature disassembly of the nanoparticles is critical for their in vivo application as non-viral 
vectors. Thus, after diluting the medium containing serum (DMEM containing 10% FBS), a marked 
increase in polyplex sizes of TMC/ON nanoparticles was observed (Fig. 6). In addition, TMC-
C10_2/ON completely disassembled after incubation in the medium containing serum. In contrast, 
the size of TMC-C18_2/ON polyplexes slightly decreased after dilution with DMEM containing 10% 
serum, possibly because some level of protein interaction with stearyl chains may lead to 
conformational rearrangements leading to different aggregation behavior. These data suggested 
that the stearyl groups can promote an enough colloidal stability of the polyplex system capable of 
withstanding the potential disaggregation forces caused by protein interactions with the polyplex 
surface or may also have caused some level of suppression of serum protein adsorption at the 
nanoparticle surface by generating thermodynamically triggered repulsion forces and entropically 
mediated interfacial water layers, preventing protein adsorption.  
PAGE analysis of TMC/ON particles after serum incubation, in general and as expected, showed a 
tendency for destabilization of the particles with consequent increased release of ON during gel 
electrophoresis, when compared to no serum incubation. This destabilization is more prominent at 
lower N/P ratios for all the polymers tested. With increasing N/P ratios (especially above 80) the 
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destabilization is less visible as differences between released ON before and after serum incubation 
are smaller, the exception being TMC-C10/ON which at N/P 160 still releases a significant amount of 
ON in comparison to the other polymers tested (Fig. 6).  
The decreased destabilization by serum proteins seen at higher N/P ratios can result from the excess 
TMC molecules that are loosely bound to the particle surface and freely exist in solution, which 
compromise the adsorption of serum components, or the relative excess of polymer compared to 
ONs, potentially resulting in more effective TMC/ON interactions. The TMC-C18_2/ON nanoparticles 
showed the highest ability to condense the ONs as compared with all other polymers. This result 
supported the results described above performed at physiological pH without the interference of 
serum in the medium and the assessment of the nanoparticle HD by DLS analysis. We can conclude 
that the length of the 18-acyl chain grafted to the TMC backbone promoted the most effective 
polymer/ON interactions because of the overall balance of electrostatic, hydrophilic and hydrophobic 
forces.  
3.5. Critical aggregation concentration (CAC)  
The study of polymer aggregation is considered interesting because this phenomenon may affect the 
biological activity of TMC and its derivatives. Polymer chains begin to aggregate with each other 
when their concentration in solution is above the CAC.42,43 The aggregates of hydrophobically 
modified chitosan are promising carriers for drug delivery due to the unique properties of chitosan 
combined with the presence of hydrophobic moieties. Understanding the impact of the hydrophobic 
substituents on the size and aggregation of the polymer in solution is quite important for designing 
drug-carrying vehicles.42 Thus, to examine this effect in more detail, we evaluated the aggregation 
behavior of N-acylated TMCs in aqueous media by fluorometry in the presence of pyrene as a 
fluorescent probe.41 In brief, when pyrene coexists with aqueous polymeric micelles or other 
hydrophobic microdomains, it preferably lies close to or inside these microdomains, causing strong 
light emission. Therefore, when pyrene is present with self-aggregated TMC derivatives, the total 
emission intensity increases, and the third highest vibrational band I3 (383 nm) is abruptly increased 
at certain concentrations of the polymer; this is referred to as the CAC. CAC values can be determined 
by measuring the intensity ratio of I1 (372 nm) and I3 (383 nm).  
In this study, changes in the intensity ratios (I1/I3) of TMC and chemically modified TMC derivative 
aggregates were calculated. For all TMC samples, at lower concentrations, I1/I3 values remained 
nearly unchanged. After further increasing the concentration, the intensity ratio started to decrease 
with the addition of polymeric amphiphiles above the CAC. Therefore, the critical aggregation 
concentration values were determined by the intercept of two straight lines, based on the 
literature,42 and the results were TMC = 0.210 mg mL−1, TMC-C10_2 = 0.199 mg mL−1 and TMC-C18_2 
= 0.329 mg mL−1. From these data, we found that TMC and TMC-C10-2 exhibited similar CAC values 
(∼0.200), very different from the value of approximately 0.33 (65%) obtained for TMC-C18-2, which 
had the longest length of the acyl chain grafted to the TMC backbone. These results indicated that 
increasing the length of the acyl chain of the TMC derivatives significantly affected the 
thermodynamic stability of the polymeric micelles in aqueous solutions. Such behavior may be a 
result of a combination of attractive and repulsive electrostatic forces of the permanent positive 
charges of the amino-quaternized groups of TMC and its derivatives as well as interactions of the 
hydrophobic chains in aqueous medium, which is different from other systems using non-quaternized 
chitosan.42,43  
 Version: Postprint (identical content as published paper) This is a self-archived document from i3S – Instituto de 
Investigação e Inovação em Saúde in the University of Porto Open Repository For Open Access to more of our 
publications, please visit http://repositorio-aberto.up.pt/  
 
A
0
1
/0
0
 
3.6. In vitro transfection: luciferase splicing reporter assay  
The HeLa/pLuc705 splice-switching reporter cell line has been previously proposed as a suitable in 
vitro model for delineating the properties of oligonucleotide delivery vectors.47 Thus, in order to 
evaluate the effects of the fatty acid chain length of modified TMCs on the ability of the resulting 
complexes to mediate oligonucleotide delivery, HeLa/Luc705 cells were transfected with complexes 
prepared with TMC and chemically modified TMC derivatives (TMC-R). For each polymer, the effects 
of polyplex composition (i.e., the N/P ratio) were studied by assessing luciferase activity using 
Lipofectamine® 2000 as a positive control in the transfection experiment (reference standard, a 
commercially available cationic lipid-based reagent). The N/P molar ratios tested were 80, 120, and 
160 as minimum levels of serum stability could only be obtained at high N/P ratios (Fig. 6). Gene 
expression was assessed 48 h post-transfection (Fig. 7). As a general trend, an increase in transfection 
activity after the N-acylation of TMC was observed for all samples. For TMC-C10_2/ON and TMC-
C5_3/ON complexes, the results of the transfection activity were modestly higher compared to that 
of TMC43/ON complexes. An increase in the grafting density of C5 units in TMC (9% vs. 3%) promoted 
an increase in transfection efficiency, which goes in line with the more favorable properties found for 
TMC-C5_9 in relation to TMC-C5_3 during this study. The TMC-C18_2/ssON complexes were shown 
to mediate the best transfection efficiency confirming the best characteristics found in the described 
characterization experiments. These results are in agreement with our previous findings33 in which a 
nearly 10-fold increase in efficiency in relation to TMC/ssON and about 50% efficacy when compared 
to Lipofectamine® 2000 alone (the positive control) have been determined. These findings strongly 
support the hypothesis that increasing the length of the hydrophobic chain of the fatty acid grafted 
to the amino-quaternized chitosan from 5 to 18 carbons promoted the formation of TMC-C18 
polyplexes with the best transfection response. In addition, the degree of substitution, although not 
studied in its entirety, also seems to play a role in the formation of transfection competent complexes 
judging from the results of TMC-C5 with different degrees of substitution (% DS). Based on the 
literature,2,3,28,44,46,48,49 it is generally accepted that smaller particles and more hydrophobic content 
enhance transfection by facilitating the entry of the polyplexes into the cells by endocytosis, in 
addition to inducing better ON condensation and polymer interactions with the cell membrane. 
Nonetheless, the balance of positive (polymer/ONs) and negative (cell membrane) charges must also 
be considered for the development of nonviral gene delivery platforms. Consistent with this potential 
application, among the different nanoparticles prepared with the different chitosan derivatives, the 
TMC-C18 based polyplexes tested in this study exhibited several key characteristics that may help to 
overcome the limitations for achieving effective transfection, such as those associated with 
electrostatic charges (attraction, repulsion), hydrophilic and hydrophobic interactions, biochemical 
stability in media, and most importantly, adequate dissociation of the TMC-C18/ssON polyplex inside 
the cells under dynamic metabolic microenvironmental conditions.  
3.7. Cellular interaction/uptake  
The correlation between the functional effect of TMC/ssON complexes, as evaluated by the luciferase 
activity assays, and the degree of cellular interaction of the complexes was then examined. 
TMC/ssON nanocomplexes, in three different N/P ratios (80, 120, 160), formed with a fluorescently 
labeled ON were used in flow cytometry experiments (Fig. 8). Cells were analyzed after 4 h incubation 
with the nanocomplexes. Of notice is the fact that this method can only give information on the total 
cellular association without discriminating between membrane-associated or internalized ON-
complexes. The results showed a complete shift in the population of cells associated with Cy5 
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fluorescence. Cells treated with TMC-C18-based nanoparticles showed the highest fluorescence 
intensity for all N/P ratios in comparison to all other TMC nanoparticles and control free ON, but 
below L2k.  
The higher hydrophobicity imparted by the C18 chains seems to play an important role in the initial 
interaction of the nanocomplexes with the cells. Still, in general, an increase in hydrophobicity 
improves cellular interactions of the TMC/ssON nanocomplexes as verified for the TMC-C5s and 
TMC-C18. The nanocomplexes formed with TMC-C10 did not follow this rule, which, however, goes 
in line with the overall instability of such nanocomplexes demonstrated in the previous experiments.  
3.8. Cell toxicity (metabolic activity)  
Cell viability was evaluated by measuring metabolic activity after incubation with the TMC/ssON 
nanocomplexes at different N/P ratios (Fig. 9). Independently of the nanocomplexes tested no 
significant alterations of the metabolic activity of the cells have been observed indicating absence of 
cytotoxicity by the TMC/ssON nanocomplexes.  
4. Conclusions  
In this study, quaternized-chitosan was successfully functionalized with different acyl chain lengths. 
The ability of the obtained acyl-TMC derivatives to form polyplexes with 18-base ssONs by assessing 
the HD, ZP, and electrophoretic characteristics was then investigated. The results demonstrated that 
the length of the acyl chains greatly influences the formation and physicochemical characteristics of 
polyplexes at the different N/P ratios tested. The stability of the formed polyplexes is perhaps one of 
the most important characteristics influenced by the acyl chain length, with the longest chain 
conferring resistance to serum destabilization and, ultimately, better transfection efficiency. The in 
vitro transfection assays using HeLa/Luc705 cell culture showed an effect of N-acyl chain length and 
degree of substitution on the extent of cellular interaction and transfection ability of the polyplexes, 
perfectly correlating with the physicochemical characteristics observed for the different systems. 
This study opens up the possibility of further enhancement of transfection capacity by rational design 
of conjugated acyl units grafted to the chitosan polymer backbone, envisaging future in vivo 
applications.  
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Scheme 1 Synthesis of N-acylated functionalized TMC polymers. 
 
Fig. 1 1H NMR spectra of TMC and TMC functionalized polymers with fatty acids [(A) TCM; (B) TMC-
C5_3; (C) TMC-C5_9; (D) TMC-C10_2; (E) TMC-C18_2]. 
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Fig. 2 (A) FT-IR spectra of TMC (a) and TMC fatty acid polymers TMC-C5_3 (b), TMC-C5_9 (c), TMC-
C10_2 (d), and TMC-C18_2 (e). (B) Evolution of the amide II band (squares) and νC–H band (circles) 
due to the TMC/fatty acid coupling reaction. 
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Fig. 3 (A) Average particle size [hydrodynamic diameter (HD)] of TMC-R/ssON complexes as a function 
of the N/P ratio (N/P range from 10 to 160). (B) Polydispersity index (Pdi) of TMC/ON complexes as a 
function of the N/P ratio. 
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Fig. 4 Zeta potential of TMC, N-acylated TMC derivatives, TMC/ssON, and N-acylated TMC/ON 
polyplexes (N/P = 80). 
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Fig. 5 Evaluation of ON release by TMC/ssON polyplexes in vitro at different N/P ratios in 20 mM 
HEPES buffer plus 5 m/v% glucose, pH = 7.4.  
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Fig. 6 Stability of complexes in serum-containing medium and HEPES buffer (pH 7.40) as determined 
by DLS and PAGE analyses. TMC/ssON complexes having an N/P ratio of 80 were incubated at 37 °C 
for 1 h in cell culture medium containing serum. 
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Fig. 7 Splice correction activity of TMC/ssON complexes in HeLa/Luc705 cells. ON was used at the 
final concentration of 0.3 μmol L−1.  
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Fig. 8 Characterization of cellular association of TMC/ssON complexes by flow cytometry. Complexes 
containing Cy5 labeled ON (Cy5-SSO705) were incubated for 24 h with HeLa/Luc705 cells at a final 
ON concentration of 0.3 μmol L−1. 
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Fig. 9 Cytotoxicity assay as evaluated by metabolic activity determination through resazurin assay. 
TMC/ssON complexes were incubated with HeLa/Luc705 cells for 24 h at a final ON concentration of 
0.3 μmol L−1.  
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Table 1 Degree of substitution (DS) of TMC-modified polymers estimated by 1H NMR analysis based 
on eqn (1) 
 
Sample N-Acyl chain (IUPAC) N-Acyl chain DS (%) 
TMC-C5_3 Pentanoyl (C5) Valeoryl (C5) 3.8 ± 0.3 
TMC-C5_9a Pentanoyl (C5) Valeoryl (C5) 9.1 ± 1.8 
TMC-C10_2 Decanoyl (C10) Decanoyl (C10) 1.7 ± 0.1 
TMC-C18_2 Octadecanoyl (C18) Stearyl (C18) 2.1 ± 0.6 
a A higher DS value was observed for TMC-C5 samples based on varying the relative 
concentrations of reagents during the synthesis procedure. 
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